Shattuck Labs Announces Presentation at Upcoming 42nd Annual J.P. Morgan Healthcare Conference
04 Gennaio 2024 - 10:05PM
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage
biotechnology company pioneering the development of bi-functional
fusion proteins as a new class of biologic medicine for the
treatment of patients with cancer and autoimmune disease, today
announced that company management will present a corporate update
and participate in one-on-one meetings at the 42nd Annual J.P.
Morgan Healthcare Conference being held in San Francisco, CA on
January 8-11, 2024.
Presentation DetailsConference: 42nd Annual
J.P. Morgan Healthcare ConferencePresenter: Taylor Schreiber, M.D.,
Ph.D., Shattuck’s Chief Executive OfficerDate: Thursday, January
11, 2024Time: 12:00 p.m. PT Location: Westin St. Francis, San
Francisco, CA
A live webcast of the presentation will be available on the
Events & Presentations section of the Company’s website. A
replay of the webcast will be archived for up to 30 days following
the presentation date.
About Shattuck Labs, Inc.Shattuck Labs, Inc.
(NASDAQ: STTK) is a clinical-stage biotechnology company pioneering
the development of bi-functional fusion proteins as a new class of
biologic medicine for the treatment of patients with cancer and
autoimmune disease. Compounds derived from Shattuck’s proprietary
Agonist Redirected Checkpoint, (“ARC®”), platform are designed to
simultaneously inhibit checkpoint molecules and activate
costimulatory molecules with a single therapeutic. The company’s
lead SL-172154 (SIRPα-Fc-CD40L) program, which is designed to block
the CD47 immune checkpoint and simultaneously agonize the CD40
pathway, is being evaluated in multiple Phase 1 trials. Shattuck
has offices in both Austin, Texas and Durham, North Carolina. For
more information, please visit: www.ShattuckLabs.com.
Investor & Media Contact: Conor
RichardsonVice President of Investor RelationsShattuck Labs,
Inc.InvestorRelations@shattucklabs.com
Grafico Azioni Shattuck Labs (NASDAQ:STTK)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Shattuck Labs (NASDAQ:STTK)
Storico
Da Mag 2023 a Mag 2024